Anzeige
Mehr »
Login
Mittwoch, 29.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Energiekrise als Chance: Mit dieser Aktie starten Sie ins Börsenjahr 2025 durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

EQS Group (EN)-Archiv vom 09.01.2025

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
09.01.EQS-PVR: Henkel AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution388EQS Voting Rights Announcement: Henkel AG & Co. KGaA Henkel AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective...
► Artikel lesen
09.01.EQS-CMS: BP p.l.c.: Release of a capital market information355EQS Post-admission Duties announcement: BP p.l.c. / Transaction in Own Shares BP p.l.c.: Release of a capital market information 09.01.2025 / 19:10 CET/CEST Dissemination...
► Artikel lesen
09.01.EQS-PVR: Nagarro SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution423EQS Voting Rights Announcement: Nagarro SE Nagarro SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide...
► Artikel lesen
09.01.EQS-PVR: PUMA SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution536EQS Voting Rights Announcement: PUMA SE PUMA SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution...
► Artikel lesen
09.01.EQS-News: ABIVAX: Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment483EQS-News: ABIVAX / Key word(s): Study Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment 09.01.2025 / 17:35 CET/CEST The issuer is solely responsible for...
► Artikel lesen
09.01.EQS-News: BioLizard nv: BioLizard Welcomes Arjan van Manen as Commercial Director and Announces Presence at JPM Week in San Francisco325EQS-News: BioLizard nv / Key word(s): Personnel/Conference BioLizard Welcomes Arjan van Manen as Commercial Director and Announces Presence at JPM Week in San Francisco 09.01.2025...
► Artikel lesen
09.01.Edison Investment Research Limited: Edison issues report on BlackRock Greater Europe Investment Trust (BRGE)333Edison Investment Research Limited Edison issues report on BlackRock Greater Europe Investment Trust (BRGE) 09-Jan-2025 / 13:34 GMT/BST The issuer is solely responsible for the...
► Artikel lesen
09.01.EQS-PVR: Commerzbank Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution856EQS Voting Rights Announcement: Commerzbank Aktiengesellschaft Commerzbank Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading...
► Artikel lesen
09.01.EQS-News: Linde plc: Linde Announces Fourth Quarter 2024 Earnings and Conference Call Schedule694EQS-News: Linde plc / Key word(s): Quarter Results Linde Announces Fourth Quarter 2024 Earnings and Conference Call Schedule 09.01.2025 / 12:00 CET/CEST The issuer is...
► Artikel lesen
09.01.Hardman & Research on Chesnara plc: Happy new acquisition273Hardman & Co Research Hardman & Research on Chesnara plc: Happy new acquisition 09-Jan-2025 / 09:20 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman...
► Artikel lesen
09.01.EQS-News: SphingoTec GmbH: Assessing Post-Cardiac Surgery Kidney Recovery Through PenKid's Emerging Role in Renal Replacement Therapy Decisions216Issuer: SphingoTec GmbH / Key word(s): Research Update/Scientific publication Assessing Post-Cardiac Surgery Kidney Recovery Through PenKid's Emerging Role in Renal Replacement...
► Artikel lesen
09.01.EQS-PVR: AIXTRON SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution527EQS Voting Rights Announcement: AIXTRON SE AIXTRON SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide...
► Artikel lesen
09.01.EQS-PVR: K+S Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution463EQS Voting Rights Announcement: K+S Aktiengesellschaft K+S Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the...
► Artikel lesen